Recent advances of the regulation roles of MicroRNA in glioblastoma

被引:14
|
作者
Yan, Chengrui [1 ]
Kong, Xiangyi [2 ,3 ,4 ,5 ]
Gong, Shun [6 ]
Liu, Fengrui [7 ]
Zhao, Yuanli [1 ]
机构
[1] Peking Univ, Hlth Sci Ctr, Int Hosp, Dept Neurosurg, Beijing 102206, Peoples R China
[2] Chinese Acad Med Sci, Canc Hosp, Natl Clin Res Ctr Canc, Dept Breast Surg Oncol,Natl Canc Ctr, Beijing 100021, Peoples R China
[3] Peking Union Med Coll, Beijing 100021, Peoples R China
[4] Univ Cambridge, Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge Breast Unit, Cambridge Biomed Campus, Cambridge CB2 0QQ, England
[5] Royal Marsden NHS Fdn Trust, Royal Marsden Hosp, Breast Surg Unit, Fulham Rd, London SW3 6JJ, England
[6] Gen Hosp Northern Theater Command, PLA Inst Neurol, Dept Neurosurg, 83 Wenhua Rd, Shenyang 110000, Peoples R China
[7] Univ Michigan, Coll Literature Sci & Arts, 500 S State St 2005, Ann Arbor, MI 48109 USA
关键词
Glioblastoma; MicroRNA; Area under curve; Prognostic model; Temozolomide; TUMOR-SUPPRESSOR; POOR-PROGNOSIS; PROMOTES; PROLIFERATION; ERYTHROPOIETIN; TEMOZOLOMIDE; EXPRESSION; MULTIFORME; RESISTANCE; BIOMARKER;
D O I
10.1007/s10147-020-01685-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Glioblastoma (GBM) is one of the most malignant neural tumors, and patients with GBM often die soon after the onset. The pathogenesis of GBM is very complicated, and there is no effective treatment for GBM. The current research results show that a variety of microRNA (miRNA) are involved in the regulation of GBM occurrence and development through specific signal pathways. Meanwhile, as a non-invasive biological indicator, there is an important clinical value of miRNA in the diagnosis and prognosis of GBM. The research of targeted miRNA treatment for GBM is still in the cell and animal model stage, although the basic research shows a good result, there is still a certain distance to the clinical application.
引用
收藏
页码:1215 / 1222
页数:8
相关论文
共 50 条
  • [31] MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma
    Tian Tian
    Ma Mingyi
    Xia Qiu
    Yang Qiu
    ONCOTARGET, 2016, 7 (48) : 79570 - 79581
  • [32] Recent advances in the molecular understanding of glioblastoma
    Bleeker, Fonnet E.
    Molenaar, Remco J.
    Leenstra, Sieger
    JOURNAL OF NEURO-ONCOLOGY, 2012, 108 (01) : 11 - 27
  • [33] Recent advances in the molecular understanding of glioblastoma
    Fonnet E. Bleeker
    Remco J. Molenaar
    Sieger Leenstra
    Journal of Neuro-Oncology, 2012, 108 : 11 - 27
  • [34] Deciphering the Labyrinthine System of the Immune Microenvironment in Recurrent Glioblastoma: Recent Original Advances and Lessons from Clinical Immunotherapeutic Approaches
    Anghileri, Elena
    Patane, Monica
    Di Ianni, Natalia
    Sambruni, Irene
    Maffezzini, Martina
    Milani, Micaela
    Maddaloni, Luisa
    Pollo, Bianca
    Eoli, Marica
    Pellegatta, Serena
    CANCERS, 2021, 13 (24)
  • [35] MicroRNA miR-100 Decreases Glioblastoma Growth by Targeting SMARCA5 and ErbB3 in Tumor-Initiating Cells
    Alrfaei, Bahauddeen M.
    Clark, Paul
    Vemuganti, Raghu
    Kuo, John S.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [36] MicroRNA Methylome Signature and Their Functional Roles in Colorectal Cancer Diagnosis, Prognosis, and Chemoresistance
    Baharudin, Rashidah
    Rus Bakarurraini, Nurul Qistina
    Ismail, Imilia
    Lee, Learn-Han
    Ab Mutalib, Nurul Syakima
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [37] MicroRNA as potential biomarkers in Glioblastoma
    Zammam Areeb
    Stanley S. Stylli
    Rachel Koldej
    David S. Ritchie
    Tali Siegal
    Andrew P. Morokoff
    Andrew H. Kaye
    Rodney B. Luwor
    Journal of Neuro-Oncology, 2015, 125 : 237 - 248
  • [38] Recent advances in the diagnostic and therapeutic roles of microRNAs in colorectal cancer progression and metastasis
    Liang, Chen
    Yang, Jing-Bo
    Lin, Xin-Yi
    Xie, Bi-Lan
    Xu, Yun-Xian
    Lin, Shu
    Xu, Tian-Wen
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [39] Recent Advances in Marine-Derived Nanoformulation for the Management of Glioblastoma
    Devi, Chanam Melody
    Deka, Kangkan
    Das, Amit Kumar
    Talukdar, Apurba
    Sola, Piyong
    MOLECULAR BIOTECHNOLOGY, 2024,
  • [40] MicroRNA biosensors for detection of glioblastoma
    Fattahi, Mehdi
    Maghsudlu, Mohadese
    Razipour, Masoumeh
    Movahedpour, Ahmad
    Ghadami, Mohsen
    Alizadeh, Mehdi
    Khatami, Seyyed Hossein
    Taheri-Anganeh, Mortaza
    Ghasemi, Ehsan
    Ghasemi, Hassan
    Aiiashi, Saleh
    Ghadami, Elham
    CLINICA CHIMICA ACTA, 2024, 556